MarketPulse

personalized medicine

24 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

GLP-1 Therapeutics Market Poised to Exceed $33B by 2030 on Formulation Innovation

GLP-1 therapeutics market projected to grow from $22B in 2025 to $33B by 2030, driven by formulation innovations like oral and extended-release therapies improving accessibility.
PFELLYNVOAZNpersonalized medicinediabetes treatment
GlobeNewswire Inc.GlobeNewswire Inc.··Castle Biosciences, Inc.

Castle Biosciences Test Predicts JAK Inhibitor Response in Atopic Dermatitis

Castle Biosciences' AdvanceAD-Tx test predicts which atopic dermatitis patients will respond to JAK inhibitors, showing 5.5x better outcomes for identified responders versus alternative treatments.
CSTLpersonalized medicineatopic dermatitis
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Human Microbiome Market Projected to Reach $3.27B by 2035

Human microbiome market expected to grow nearly fourfold to $3.27B by 2035, driven by advancing sequencing technology and 215+ therapeutic candidates in clinical development.
NSRGYMCRBclinical trialspersonalized medicine
GlobeNewswire Inc.GlobeNewswire Inc.··Towards Healthcare

SNP Genotyping Market Poised to Double to $19.5B by 2034

SNP genotyping market projected to grow from $8.08B (2026) to $19.48B (2034) at 11.7% annual rate, driven by personalized medicine adoption and genomic technology advances.
ILMNRHHBYTMOREGNMYGNpersonalized medicineprecision medicine